Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the effect of RO4917838 compared to placebo on negative symptoms based on the mean change from baseline in Positive and Negative Syndrome Scale (PANSS) negative factor score after 8 weeks of treatment
Critère d'inclusion
- Schizophrenia - This study will be conducted to investigate whether or not administration of RO4917838 along with their current antipsychotic regimen to stable patients can lead to further improvement in symptoms including the potential for improving cognitive function and negative symptoms in addition to improvement in positive symptoms